Drug intelligence / Profile preview

Eugenol

Development stage
Phase 3
Modality
Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Topical, Dental, Oral
01

Overview

Eugenol is a naturally occurring phenolic compound found in several plants such as clove, cinnamon, and bay leaves. It is widely used as a topical antiseptic and analgesic in dental preparations—often combined with zinc oxide for root canal sealing and pain control—and for the temporary relief of toothaches. Eugenol exhibits anti-inflammatory, antioxidant, antimicrobial, antipyretic, neuroprotective, antifungal, and analgesic properties. Its mechanism of action includes inhibition of sodium channel currents (which underlies its local anesthetic effect), positive allosteric modulation of GABA-A receptors (contributing to general anesthetic properties), inhibition of pro-inflammatory mediators like nitric oxide synthase and cyclooxygenase enzymes, scavenging reactive oxygen species (antioxidant effect), and mild monoamine oxidase inhibition in vitro. Although not currently available in any FDA-approved products as a pharmaceutical drug or over-the-counter medication in the US market, it remains present in unapproved OTC dental products for toothache relief[1][3][5][6].

Brand names
Eugenol Toothache Medication
Other names
clove oil4-allyl-2-methoxyphenoleugenic acid
02

Targets

COXNF-κBSCN1A (Voltage-gated sodium channel protein type 1 subunit alpha)NOS1 (nNOS)MAOB (Monoamine oxidase B)GABRR (GABA-A receptor subunit rho)MAOA (Monoamine oxidase A)

Beyond the preview

Go deeper on Eugenol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eugenol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call